<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:department>Sch of Biological Sciences</gtr:department><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/EF487274-CC13-4315-8734-14C1977A4AD2"><gtr:id>EF487274-CC13-4315-8734-14C1977A4AD2</gtr:id><gtr:firstName>Austin</gtr:firstName><gtr:surname>Smith</gtr:surname><gtr:orcidId>0000-0002-3029-4682</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/A32C2121-1A1C-4EAD-A0EA-32BB939BAFCE"><gtr:id>A32C2121-1A1C-4EAD-A0EA-32BB939BAFCE</gtr:id><gtr:firstName>Clare</gtr:firstName><gtr:otherNames>Catherine</gtr:otherNames><gtr:surname>Blackburn</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0400690"><gtr:id>1DA7FCDC-7B14-40F5-8158-CC6F711DDEDF</gtr:id><gtr:title>Derivation of thymic epithelial progenitor cells from ES cells</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0400690</gtr:grantReference><gtr:abstractText>Cellular immune responses, which control infection, allergy and transplant rejection, are co-ordinated and effected by T-cells. T-cell development takes place only in the thymus and depends on several specialized cell-types, called thymic epithelial cells, that are found only in that organ. The thymus is very active in children and young adults, but stops functioning in older people. This leads to problems in people who lose their original T cells such as bone marrow and organ transplantation patients, whose T cells have to be killed before the transplant can be accepted, and HIV patients. These patients need to generate new T cells in order to fight infections. My laboratory has recently identified a type of cell in the mouse embryonic thymus that can grow into a fully functional thymus when transplanted to a different site in the body. These cells, called thymic epithelial progenitor cells , may be useful for restoring immune function in patients with low T cell levels, either by transplantation of thymic epithelial progenitor cells to boost thymus activity, or by providing a way to grow T-cells efficiently in the laboratory. This could for instance provide bone marrow or organ transplant patients with safe, laboratory-grown T-cells while their own T cells were still regenerating. At the moment, the only source of thymic epithelial progenitor cells is embryonic thymus tissue. This presents a major barrier to the use of these cells for therapeutic purposes. Embryonic stem cells (ES cells) are a type of cell that can be grown indefinitely in the laboratory but can also differentiate into all cell-types and tissues found in the body (more information on ES cells, and other stem cell types, can be found on our website, http://www.iscr.ed.ac.uk/stemcells.html). Recently, scientists have successfully used ES cells to generate other more mature cell types in the laboratory. The cell types generated so far include neural stem cells, which may be used to repair damaged nerves in the future, and blood cells. The aim of this work is to establish a method for generating thymic epithelial progenitor cells from ES cells. This method would allow large numbers of thymic epithelial progenitor cells to be generated in the laboratory for therapeutic use. The study of thymic epithelial progenitor cells will also contribute important information to studies on how stem or progenitor cells function in general.</gtr:abstractText><gtr:technicalSummary>Restoration of immune competence after transplantation requires thymus-dependent reconstitution of the T cell compartment and is problematic due to thymic involution. Interest therefore exists in the potential for therapeutic enhancement of thymus activity and the possibility of large-scale in vitro generation of defined T cell populations. We have recently isolated progenitor cells from mid-gestation mouse embryonic thymi that are sufficient to generate a functional thymus on transplantation. This population is likely to correspond to a common thymic epithelial progenitor cell (TEPC), that can differentiate into all thymic epithelial cell-types. TEPC have predicted clinical uses for boosting thymus function in transplant patients and to provide a means of ?patching? transplantation protocols using in vitro generated customised human T cell repertoires. However, at present they can be obtained only from foetal tissue. This proposal aims to provide a scaleable source via the direct differentiation and selective amplification of TEPC from ES cell cultures, with the long term goal of generating human ES-TEPC for clinical use.</gtr:technicalSummary><gtr:fund><gtr:end>2008-08-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2005-09-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>305183</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Centre for Regenerative Medicine</gtr:department><gtr:description>Generation of human ES cell reporter lines for identification of thymic epithelial lineage cells.</gtr:description><gtr:id>308C76FD-F8D2-4EC8-9D9E-429CB981B4C1</gtr:id><gtr:impact>Research materials.</gtr:impact><gtr:partnerContribution>My collaborator contributes expertise in gene targeting in human ES cells, and in vector design.</gtr:partnerContribution><gtr:piContribution>We contribute expertise in thymic epithelial cell biology, thymus organogenesis and ES differentiation to definiteive endoderm</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>84000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>School of Biological Sciences Postgraduate Scholarship</gtr:description><gtr:end>2011-09-02</gtr:end><gtr:fundingOrg>University of Edinburgh</gtr:fundingOrg><gtr:id>7FEB88A8-0C5F-4EDF-BC94-7A2484088A47</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>100000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC iCASE PhD studentship</gtr:description><gtr:end>2019-08-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>095E133B-C3FE-435A-A20C-5A919137C232</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2015-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>84000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>School of Biological Sciences Postgraduate Scholarship</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>University of Edinburgh</gtr:fundingOrg><gtr:id>70928C97-B0BB-4CA1-A807-643B297D1383</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>6000000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>EU FP7 Collaborative Project</gtr:description><gtr:end>2017-09-02</gtr:end><gtr:fundingOrg>European Commission (EC)</gtr:fundingOrg><gtr:fundingRef>602587</gtr:fundingRef><gtr:id>101BC1F7-A1AE-42EB-BF67-2CBECECA022C</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>This is an ES cell line in which CreERt2 is knocked in to exon 1 of the mouse Plet1 locus, such that it replaces Plet1 expression (knockin-knockout).

This ES cell line has also been used to generate a Plet1CreERt2 transgenic mouse line. The CreERt2 is not functional unfortunately, but the mouse line is a Plet1 null.</gtr:description><gtr:id>12AACE3E-F87B-420C-9168-F02E70129490</gtr:id><gtr:impact>N/A</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>ES cell line Plet1CreERt2</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>This is an ES cell line and corresponding mouse strain carrying a revertible hypomorphic allele of Foxn1, where a flowed GFP cassette is knocked in to the Foxn1 locus such that it severely disrupts Foxn1 transcription.</gtr:description><gtr:id>10BDA6D1-13B5-4269-8135-5C40BE434060</gtr:id><gtr:impact>This allele will be useful for reporting Foxn1 activity in vivo and in vitro, while minimizing the differentiation promoting activity of Foxn1.</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Foxn1G</gtr:title><gtr:type>Cell line</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F25D2E41-E310-412A-A5EE-52861EECB13E"><gtr:id>F25D2E41-E310-412A-A5EE-52861EECB13E</gtr:id><gtr:title>Identification of Plet-1 as a specific marker of early thymic epithelial progenitor cells.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f357e011161743b42fb9f38736642a91"><gtr:id>f357e011161743b42fb9f38736642a91</gtr:id><gtr:otherNames>Depreter MG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/08764EF4-B5EA-4774-9765-76255D4DE00C"><gtr:id>08764EF4-B5EA-4774-9765-76255D4DE00C</gtr:id><gtr:title>Construction of a functional thymic microenvironment from pluripotent stem cells for the induction of central tolerance.</gtr:title><gtr:parentPublicationTitle>Regenerative medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/46d91cb8679299a78c74cf0dccb42fa5"><gtr:id>46d91cb8679299a78c74cf0dccb42fa5</gtr:id><gtr:otherNames>Bredenkamp N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1746-0751</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0400690</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>DD81206B-5EB4-4BCC-AEF7-808A64606E0E</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>5.2  Cellular and gene therapies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>